All-natural-molecule, bioluminescent photodynamic therapy results in complete tumor regression and prevents metastasis.
Abstract
Self-luminescent photodynamic therapy (PDT) has gained attention owing to its potential to enable effective phototherapy without the bottleneck of shallow light penetration into tissues. However, the biosafety concerns and low cytotoxic effect of self-luminescent reagents in vivo have been problems. Here, we demonstrate efficacious bioluminescence (BL)-PDT by using bioluminescence resonance energy transfer (BRET) conjugates of a clinically approved photosensitizer, Chlorin e6, and a luciferase, Renilla reniformis; both derived from biocompatible, natural molecules. With over 80% biophoton utilization efficiency and membrane-fusion liposome-assisted intracellular delivery, these conjugates produce effective, targeted cancer cell killing. Specifically, in an orthotopic mouse model of 4T1 triple-negative breast cancer, BL-PDT showed strong therapeutic effects on large primary tumors and a neoadjuvant outcome in invasive tumors. Furthermore, BL-PDT resulted in complete tumor remission and prevention of metastasis for early-stage tumors. Our results demonstrate the promise of molecularly-activated, clinically viable, depth-unlimited phototherapy.
AI evidence extraction
Main findings
Bioluminescence photodynamic therapy (BL-PDT) using BRET conjugates of Chlorin e6 and Renilla reniformis luciferase produced effective targeted cancer cell killing. In an orthotopic mouse model of 4T1 triple-negative breast cancer, BL-PDT showed strong therapeutic effects on large primary tumors and, for early-stage tumors, complete remission and prevention of metastasis.
Outcomes measured
- Targeted cancer cell killing
- Therapeutic effects on large primary tumors
- Neoadjuvant outcome in invasive tumors
- Complete tumor remission (early-stage tumors)
- Prevention of metastasis (early-stage tumors)
Limitations
- Sample size not reported in abstract
- No EMF exposure parameters (frequency, SAR, duration) described in abstract
- Details on controls/comparators and statistical results not provided in abstract
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": null,
"source": null,
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Orthotopic mouse model of 4T1 triple-negative breast cancer",
"sample_size": null,
"outcomes": [
"Targeted cancer cell killing",
"Therapeutic effects on large primary tumors",
"Neoadjuvant outcome in invasive tumors",
"Complete tumor remission (early-stage tumors)",
"Prevention of metastasis (early-stage tumors)"
],
"main_findings": "Bioluminescence photodynamic therapy (BL-PDT) using BRET conjugates of Chlorin e6 and Renilla reniformis luciferase produced effective targeted cancer cell killing. In an orthotopic mouse model of 4T1 triple-negative breast cancer, BL-PDT showed strong therapeutic effects on large primary tumors and, for early-stage tumors, complete remission and prevention of metastasis.",
"effect_direction": "benefit",
"limitations": [
"Sample size not reported in abstract",
"No EMF exposure parameters (frequency, SAR, duration) described in abstract",
"Details on controls/comparators and statistical results not provided in abstract"
],
"evidence_strength": "insufficient",
"confidence": 0.7399999999999999911182158029987476766109466552734375,
"peer_reviewed_likely": "yes",
"keywords": [
"photodynamic therapy",
"bioluminescence",
"bioluminescence resonance energy transfer",
"BRET",
"Chlorin e6",
"Renilla reniformis luciferase",
"liposome-assisted delivery",
"4T1",
"triple-negative breast cancer",
"mouse model",
"tumor regression",
"metastasis prevention"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.